MONDELLI, MARIA MADDALENA
 Distribuzione geografica
Continente #
EU - Europa 352
NA - Nord America 162
AS - Asia 134
SA - Sud America 10
AF - Africa 4
OC - Oceania 1
Totale 663
Nazione #
GB - Regno Unito 279
US - Stati Uniti d'America 155
SG - Singapore 52
CN - Cina 38
IT - Italia 15
HK - Hong Kong 11
SE - Svezia 9
BD - Bangladesh 8
BR - Brasile 8
ES - Italia 8
NL - Olanda 8
VN - Vietnam 8
DE - Germania 7
IN - India 7
RU - Federazione Russa 6
FR - Francia 5
IE - Irlanda 5
CA - Canada 4
CI - Costa d'Avorio 4
DK - Danimarca 4
FI - Finlandia 3
ID - Indonesia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CL - Cile 1
CO - Colombia 1
CU - Cuba 1
CZ - Repubblica Ceca 1
IL - Israele 1
IQ - Iraq 1
JM - Giamaica 1
KR - Corea 1
LK - Sri Lanka 1
MX - Messico 1
PK - Pakistan 1
PS - Palestinian Territory 1
RO - Romania 1
TR - Turchia 1
UA - Ucraina 1
Totale 663
Città #
Southend 277
Singapore 30
Ashburn 24
Chandler 22
Fairfield 11
Hong Kong 9
Woodbridge 9
Beijing 8
San Jose 7
Hefei 6
Houston 6
Dublin 5
Abidjan 4
Alcalá de Henares 4
Ann Arbor 4
Cambridge 4
Los Angeles 4
Madrid 4
Milan 4
New York 4
Santa Clara 4
Council Bluffs 3
Frankfurt am Main 3
Helsinki 3
Ho Chi Minh City 3
Jinan 3
Phoenix 3
Seattle 3
São Paulo 3
Wilmington 3
Cangzhou 2
Columbus 2
Dallas 2
Dearborn 2
Haiphong 2
Hanoi 2
Huzhou 2
Jakarta 2
Lauterbourg 2
Moscow 2
New Delhi 2
Nuremberg 2
Redwood City 2
The Dalles 2
Toronto 2
Amsterdam 1
Ankara 1
Atlanta 1
Baghdad 1
Barnet 1
Beaverton 1
Bengaluru 1
Bexley 1
Birigui 1
Boardman 1
Brampton 1
Brooklyn 1
Buffalo 1
Central District 1
Charlotte 1
Chennai 1
Colombo 1
Contagem 1
Coroatá 1
Daurāla 1
Des Moines 1
Dubai 1
Estación Colina 1
Florence 1
Fuzhou 1
Grafing 1
Halifax 1
Havana 1
Hillsboro 1
Ipatinga 1
Islamabad 1
Kanpur 1
Kent 1
Kingston 1
Medellín 1
Munich 1
Ningbo 1
Orem 1
Orizaba 1
Quảng Ninh 1
Rome 1
Roubaix 1
San Diego 1
Shanghai 1
Shenzhen 1
Sorocaba 1
Statesboro 1
Sydney 1
The Woodlands 1
Verona 1
Totale 557
Nome #
null 363
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 190
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 119
Totale 672
Categoria #
all - tutte 1.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 16 12
2021/202264 15 12 13 11 1 2 0 1 2 3 2 2
2022/202341 6 7 1 6 3 5 1 2 10 0 0 0
2023/202416 2 1 0 1 5 1 0 1 0 1 1 3
2024/202597 6 8 1 13 7 3 3 4 3 12 15 22
2025/2026153 15 15 16 18 13 7 19 11 8 12 19 0
Totale 672